l 645151 has been researched along with alpha-chymotrypsin in 1 studies
| Studies (l 645151) | Trials (l 645151) | Recent Studies (post-2010) (l 645151) | Studies (alpha-chymotrypsin) | Trials (alpha-chymotrypsin) | Recent Studies (post-2010) (alpha-chymotrypsin) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 14,743 | 142 | 1,015 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conquet, P; Gautheron, P; Schmitt, C; Share, NN; Smith, RL; Stone, CA; Sugrue, MF; Viader, MP | 1 |
1 other study(ies) available for l 645151 and alpha-chymotrypsin
| Article | Year |
|---|---|
On the pharmacology of L-645,151: a topically effective ocular hypotensive carbonic anhydrase inhibitor.
Topics: Administration, Topical; Animals; Benzothiazoles; Carbonic Anhydrase Inhibitors; Chymotrypsin; Diuretics; Dogs; Eye; Female; Intraocular Pressure; Male; Rabbits; Suspensions; Thiadiazoles; Thiazoles; Tissue Distribution | 1985 |